参考文献/References:
[1]LOZANO R,NAGHAVI MK,FOREMAN K,et al.Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010:a systematic analysis for the Global Burden of Disease Study 2010[J].Lancet,2012,380(9859):2095-2128.
[2]葛均波,徐永健.内科学[M].第 8 版.北京:人民卫生出版社,2013.
[3]王吉耀.内科学[M].北京:人民卫生出版社,2002:245-246.
[4]彭金祥,姚祖培.冠心病合并抑郁的中西医研究进展[J].中西医结合心脑血管病杂志,2010,8(10):1234-1236.
[5]王中平,刘凡,王玲,等.血脂异常与冠心病研究进展[J].四川解剖学杂志,2010,18(3):45-48.
[6]Barua RS,Ambrose JA.Mechanisms of coronary thrombosis in cigarette smoke exposure [J].Arteriosclerosis Thrombosis and Vascular Biology,2013,33(7):1460-1467.
[7]PERTICONE M,TRIPEPI G,MAIO R,et al.Risk reclassification ability of uric acid for cardiovascular outcomes in essential hypertension[J].Int J Cardiol,2017(243):473-478.
[8]贺娜娜,张菲斐,韩战营,等.冠心病患者血尿酸及糖化血红蛋白水平与冠脉病变的关系[J].实用医学杂志,2012,28(7):1088-1090.
[9]巩洁,任晖,高天林,等.冠心病患者血清尿酸与平均血小板体积的关系及二者对心血管事件的预测价值[J].中国动脉硬化杂志,2016,24(8):821-824.
相似文献/References:
[1]袁 帅,邢晓博,李 晓,等.MTHFR基因多态性与中年男性冠状动脉病变程度的相关研究[J].医学信息,2018,31(03):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
YUAN Shuai,XING Xiao-bo,LI Xiao,et al.Association of MTHFR Gene Polymorphism with Coronary Artery Lesions in Middle-aged Men[J].Journal of Medical Information,2018,31(07):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
[2]张挺挺.经股和桡动脉介入治疗冠心病的临床疗效对比[J].医学信息,2018,31(03):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
ZHANG Ting-ting.Comparison of Clinical Effects of Interventional Treatment of Coronary Heart Disease by Femoral and Radial Artery[J].Journal of Medical Information,2018,31(07):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
[3]迮艳华.稳心颗粒联合美托洛尔治疗冠心病心律失常的疗效分析[J].医学信息,2018,31(03):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
ZE Yan-hua.Therapeutic Effect of Wenxin Granule Combined with Metoprolol on Arrhythmia of Coronary Heart Disease[J].Journal of Medical Information,2018,31(07):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
[4]张 旭.冠心病心绞痛患者进行护理干预的临床效果及
对护理质量影响研究[J].医学信息,2018,31(05):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
ZHANG Xu.Clinical Effect of Nursing Intervention in Patients with Angina Pectoris of Coronary Heart Disease and its Influence on Nursing Quality[J].Journal of Medical Information,2018,31(07):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
[5]王 坤,张永春.血清胆红素水平、单核细胞数、红细胞分布宽度与
冠状动脉病变程度的关系[J].医学信息,2018,31(08):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
WANG Kun,ZHANG Yong-chun.Relationship between Serum Bilirubin Level,Monocyte Count,Red Blood Cell Distribution Width and Severity of Coronary Artery Disease[J].Journal of Medical Information,2018,31(07):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
[6]毛红岩.冠状动脉介入治疗冠心病的疗效及
对患者血清炎症因子的影响[J].医学信息,2018,31(10):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
MAO Hong-yan.Effect of Coronary Intervention on Coronary Heart Disease and its Influence on Serum Inflammatory Factors[J].Journal of Medical Information,2018,31(07):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
[7]杨锦龙,刘 欢,吕秋菊,等.非糖尿病患者糖化血红蛋白和胰岛素抵抗与
冠状动脉病变程度的相关性研究[J].医学信息,2018,31(10):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
YANG Jin-long,LIU Huan,LV Qiu-ju,et al.Correlation between Glycosylated Hemoglobin and Insulin Resistance and Severity of Coronary Artery Disease in Non-diabetic Patients[J].Journal of Medical Information,2018,31(07):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
[8]李 铎,王建华.盐酸曲美他嗪片辅助治疗对冠心病伴心力衰竭患者氧化应激、心肌功能的影响[J].医学信息,2018,31(10):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
LI Duo,WANG Jian-hua.Effect of Trimetazidine Hydrochloride Tablets Adjuvant Therapy on Oxidative Stress and Myocardial Function in Patients with Coronary Heart Disease Complicated with Heart Failure[J].Journal of Medical Information,2018,31(07):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
[9]宫丽萍.血府逐瘀汤加减治疗气滞血瘀型冠心病心绞痛的疗效研究[J].医学信息,2018,31(12):145.[doi:10.3969/j.issn.1006-1959.2018.12.046]
GONG Li-ping.Therapeutic Effect of Xuefu Zhuyu Decoction on Angina Pectoris with Qi Stagnation and Blood Stasis[J].Journal of Medical Information,2018,31(07):145.[doi:10.3969/j.issn.1006-1959.2018.12.046]
[10]王 毅.阿托伐他汀联合曲美他嗪治疗冠心病的临床效果评价[J].医学信息,2018,31(13):139.[doi:10.3969/j.issn.1006-1959.2018.13.041]
WANG Yi.Clinical Evaluation of Atto Vastatin Combined with Trimetazidine in the Treatment of Coronary Atherosclerotic Heart Disease[J].Journal of Medical Information,2018,31(07):139.[doi:10.3969/j.issn.1006-1959.2018.13.041]